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Abstract
The spread of intramuscularly inoculated poliovirus to the central nervous system (CNS) has been documented in humans, monkeys, and
mice transgenic for the human poliovirus receptor. Poliovirus spread is thought to be due to infection of the peripheral nerve and retrograde
transport of poliovirus through the axon to the neuron cell body, where final virus uncoating occurs and translation/replication ensues. In
previous studies, we have shown that polio-based vectors (replicons) can be used for gene delivery to motor neurons of the CNS. Using a
replicon that encodes green fluorescent protein (GFP), we found that following intrathecal inoculation, GFP expression was confined to
motorneurons of the spinal cord. To further characterize the gene expression of poliovirus in the periphery and CNS, we have intramus-
cularly inoculated transgenic mice with poliovirus replicons encoding GFP. Expression of GFP was demonstrated in the muscle, sciatic
nerve, dorsal root ganglion, and the ventral horn motorneurons following intramuscular inoculation. There was no evidence of paralysis or
behavioral abnormalities in the mice following intramuscular inoculation of the replicon encoding GFP. Injection of replicon RNA alone
(naked RNA) into the muscle of transgenic mice or rats, which do not express the poliovirus receptor, also resulted in expression of GFP
in the muscle, sciatic nerve, dorsal root ganglion, and ventral horn motorneurons, indicating that transport of the replicon RNA from the
periphery to CNS had occurred. GFP expression was found in the muscles and sciatic nerve as early as 6 h after injection of replicons or
replicon RNA, even after sciatic nerve section. Analysis at longer times postinjection revealed GFP expression similar to 6 h levels in the
cut sciatic nerves and robust expression in the nerves of uncut animals. The infection and expression of GFP in the CNS following
intramuscular inoculation of encapsidated replicons encoding GFP occurred in juvenile or adult animals. The expression of GFP in the CNS
of juvenile animals was more intense and lasted for up to 5 weeks, in contrast to the duration of expression of approximately 96 h for adult
animals. The results of these studies establish that poliovirus replicon RNA is expressed locally within the sciatic nerve and transported from
the periphery to the CNS via axonal transport and support the potential of replicons for gene delivery to the CNS.
© 2003 Elsevier Science (USA). All rights reserved.
Keywords: Replicon; Poliovirus; Central nervous system; Localized expression
Introduction
One of the hallmarks of poliovirus infection in primates
and humans is the destruction of motor neurons at all levels
of the spinal cord, brain stem, and motor cortex (Bodian,
1949; Bodian and Howe, 1955). As a consequence of this
destruction, an acute disease of the central nervous system
(CNS) occurs that is referred to as poliomyelitis (Bodian,
1949; Bodian and Howe, 1955). Poliovirus, the causative
agent of poliomyelitis, is an enterovirus belonging to the
family of the Picornaviridae, a family of small RNA vi-
ruses. In the natural setting, poliovirus is transmitted via a
fecal/oral route. Following ingestion, the virus multiplies in
the alimentary mucosa; the tonsils and Peyer’s patches are
invaded early in the course of infection. As the infection
proceeds, the virus moves into the deep cervical and mes-
enteric lymph nodes and finally into the blood (viremia), a
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prerequisite for spread into the CNS for poliomyelitis
(Sabin, 1956). Vaccines effective against poliomyelitis gen-
erate antibodies that reduce viremia and the subsequent
spread to the CNS (Sabin and Boulger, 1973).
Studies on the pathogenesis of poliovirus have been
facilitated by the development of a small animal model
(transgenic mice) that express the poliovirus receptor (PVR)
and can recapitulate the major features of poliovirus infec-
tion in the CNS (Deatly et al., 1998, 1999; Ren and Ra-
caniello, 1992a, 1992b). Infection of these animals by a
variety of routes leads to the generation of symptoms re-
sembling poliomyelitis. Although the use of these mice in
some analyses has been compromised by the inability to
reproducibly infect via the oral route, previous studies have
established that poliovirus can readily infect mice when
given via intramuscular inoculation (Arita et al., 1999; Ren
and Racaniello, 1992b). In this case, studies have shown
that poliovirus can infect (albeit modestly) the muscle cells
of the inoculated animals. The virus has the capacity to
infect the peripheral nerves at the neuromuscular junction
and is transported to the CNS via the sciatic nerve after
injection into any of the lower limb muscles supplied by this
nerve (Ren and Racaniello, 1992b). The retrograde transport
of the virus is rapid and thus viewed as using the fast axonal
transport system (Ohka et al., 1998). Analysis of the sciatic
nerve following intramuscular inoculation with poliovirus
revealed that intact virus particles (by virtue of their sedi-
mentation at 160S) were found in and around the sciatic
nerve. Recent studies have shown that the poliovirus recep-
tor complexes with Tctex-1, a light chain-1 of the dynein
complex. The PVR-Tctex-1-virus complex is postulated to
undergo retrograde transport to the CNS motor neuron,
where the poliovirus particles would completely uncoat in
the cytoplasm of the neurons to initiate a productive infec-
tion in the CNS (Mueller et al., 2002). It is not clear how the
virus remains partially uncoated prior to transport to the
cytoplasm of the neurons and what elements trigger the final
uncoating.
Previous studies from this laboratory have described the
construction and characterization of poliovirus genomes in
which the capsid proteins have been substituted with a
foreign gene (Ansardi et al., 2001; Bledsoe et al., 2000a,
2000b; Porter et al., 1995, 1996, 1998). These RNA ge-
nomes, referred to as replicons, possess the capacity to
undergo self-amplification and expression of the foreign
gene in the cytoplasm of cells. To deliver these replicons to
cells, we have developed a procedure in which the replicons
are encapsidated into authentic poliovirus capsids that are
supplied in trans from a recombinant vaccinia virus (An-
sardi et al., 1993, 1996). The ability to encapsidate replicon
genomes into authentic capsids means that replicons main-
tain tropism for infection of cells that express PVR. Repli-
cons possess the capacity to infect cells and undergo a
single round of replication, without the possibility of spread
to neighboring cells. We have utilized replicons encoding
reporter proteins [luciferase and green fluorescent protein
(GFP)] to elucidate aspects of poliovirus pathogenesis in the
CNS (Bledsoe et al., 2000a, 2000b; Jackson et al., 2001).
The results of our studies establish that poliovirus replicon
infection occurs mainly in motor neurons of the CNS. Ex-
pression of the foreign gene from the replicon is dependent
on RNA replication, peaks at 24–48 h postinoculation, and
by 96 h the majority of the foreign gene expression has
subsided. Replicons also have a unique capacity to distrib-
ute throughout the CNS via cerebral spinal fluid (CSF) and
do not cause disease, even following multiple inoculations
into the same animals (Jackson et al., 2001). Proteins with
biological activity such as cytokines can be expressed in the
CNS using replicon-based vectors (Bledsoe et al., 2000b).
All of our studies to date have used replicons given
directly into the CNS of adult transgenic mice via intrathe-
cal inoculation. Recent studies have suggested that the ex-
pression of the poliovirus receptor is greatest prior to birth
and declines as the animal ages (Gromeier et al., 2000). The
expression of the receptor in mice parallels the susceptibil-
ity to poliovirus in humans, because the young are most
susceptible to poliovirus infections. To examine the effects
that the age of the animal has on the susceptibility to
replicons, we undertook a study in which replicons encod-
ing GFP were administered to 3-week-old and adult trans-
genic mice. The results of our studies established that in-
tramuscular inoculation of replicons encoding GFP resulted
in expression within the muscle as well as in the peripheral
nerve branches. We also observed GFP expression in the
sciatic nerve as well as in CNS neurons; the GFP expression
was prolonged in the younger compared to the older ani-
mals. To ascertain whether the expression was solely due to
transport of intact replicon particles via the axonal transport
system, we directly injected the naked replicon RNA (non-
encapsidated) into the muscle of transgenic mice. Once
again, we found expression of GFP within the muscles of
the injected animals as well as in the sciatic nerve and CNS
neurons. Finally, we show localized expression of GFP
from replicons in the sciatic nerve of animals. The results of
these studies are discussed with respect to poliovirus patho-
genesis and the capacity of the replicon RNA to be trans-
ported via the fast axonal transport system.
Results
Expression of GFP in the periphery and CNS following
intramuscular inoculation in PVR mice
Previous studies have established that the transgenic
mice are susceptible to infection with poliovirus following
intramuscular inoculation (Ohka et al., 1998; Ren and Ra-
caniello, 1992b). To examine the extent of infection follow-
ing intramuscular inoculation, we used the replicon encod-
ing GFP for our studies because we have experience with
the immunochemistry to detect expression, and the expres-
sion of GFP is dependent on the infection and genome
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replication of the replicon encoding GFP (Bledsoe et al.,
2000a; Choi et al., 1991; Jackson et al., 2001). For these
studies, we inoculated adult mice (n  30) intramuscularly
with replicons encoding GFP and sacrificed these animals at
various intervals after injection. The majority of the adult
mice sacrificed within 5 days after injection (18/22) showed
intense GFP expressing within the muscle, sciatic nerve,
and all levels of the spinal cord. Animals sacrificed at later
intervals (2–12 weeks) displayed lower levels of GFP ex-
pression in the muscle only (data not shown). Routine his-
tological analyses using hematoxylin and eosin revealed no
influx of inflammatory cells in response to the injection of
replicons. In all groups, extravasated blood was evident in
the injected area of the muscle but no additional inflamma-
tory infiltrate was present. No inflammation was noted in the
sciatic nerve or spinal cord. The neurons and other cell types
within the spinal cord appeared healthy (e.g., abundant Nissl
substance was distributed evenly throughout the cytoplasm
in the motor and sensory neurons). We observed no influx of
glial cells around the neurons or perivascular cuffing char-
acteristic of wild-type poliovirus infection (Bodian, 1949).
Immunofluorescent analyses of the semitendinosus mus-
cle (location 1 in Fig. 1b ) following injection of poliovirus
replicons encoding GFP revealed intense GFP expression
within the muscle along the perimeter of the cell (white
arrowheads in Fig. 2a). GFP expression was found through-
out the muscle myofibrils and the characteristic banding of
the muscle filaments was evident. Branches of the sciatic
nerve found within the muscle (white arrow) exhibit abun-
dant GFP expression as reflected by the intense immuno-
fluorescence. Muscle tissue taken from the opposite leg of
the same animal demonstrated no GFP expression, indicat-
ing that the GFP expression was localized to the site of
replicon injection (data not shown). Identical processing of
muscles taken from control animals that had received an
injection of artificial CSF (n  7) (Fig. 2b) and sacrificed at
24 or 72 h demonstrated no GFP expression in the muscle
cell (white arrows); the diffuse level of fluorescence ob-
served was probably due to the paraformaldehyde used for
fixation.
Previous studies have found that following intramuscular
inoculation poliovirus is found in the sciatic nerve (Ohka et
al., 1998; Ren and Racaniello, 1992b). We next wanted to
determine if GFP was present in the sciatic nerve fibers
following injection. It is important to note that we did not
inject the sciatic nerve with replicons. Analysis of sections
from the sciatic nerve for GFP (location 2 in Fig. 1b)
revealed a dense pattern of GFP expression within the fibers
of the nerve (Fig. 2c). The fibers expressing GFP are also
labeled by the neuronal marker NeuN, so that the combined
fluorescence appears yellow in the merged view (Fig. 2d).
GFP expression indicates that the replicon encoding GFP
has probably undergone the genome replication that is re-
quired for high-level GFP expression (Bledsoe et al., 2000a;
C.D. Morrow, unpublished observations).
We next examined whether neurons in the dorsal root
ganglion expressed GFP following intramuscular inocula-
tion of replicons. Sections taken from the dorsal root gan-
glion (location 3 in Fig. 1b) demonstrate GFP expression in
the cell bodies (Fig. 2e); the neuronal identity of these cells
is confirmed by colocalization of the NeuN antigen (Fig.
2f). Note that examination of Fig. 2f reveals less NeuN
staining in some of the nuclei of the cell bodies since the
complete nucleus of these neuronal cell bodies lies out of
the plane of section. Finally, we examined the neurons
within the CNS for GFP expression (location 4, Fig. 1b).
Within the spinal cord, GFP expression following injection
of poliovirus replicons is found in the cytoplasm of motor
neurons of the ventral horn of the spinal cord and in scat-
tered fibers entering the dorsal horn. With the exception of
labeled fibers entering the dorsal horn, GFP expression was
not evident throughout the spinal cord white matter. GFP
expression was not found in the motor cortex suggesting
that transynaptic transfer of replicons occurs only at the
neuromuscular junction and does not occur centrally. The
pattern of GFP expression within the cytoplasm of the
ventral horn motor neurons was similar to the distribution of
Nissl substance (rough endoplasmic reticulum) found in
these large triangularly shaped cells. The long axons ema-
nating from these motorneurons are the nerve fibers forming
the motor component of peripheral nerves (such as the
sciatic nerve, Fig. 1b) and the branches synapsing within the
muscles at the neuromuscular junction (Fig. 1b; Fig. 2a,
white arrow).
Intramuscular inoculation of naked RNA results in
GFP expression in periphery and CNS
Previous studies have reported that poliovirions have the
capacity for transport via the fast axonal transport system
from the periphery to the CNS (Ohka et al., 1998). In these
studies, it was shown that the intact virus particle (160S
virion) was transported to the CNS. Presumably, the trans-
ported virus would then undergo uncoating in the cytoplasm
of the neurons in the CNS. From the studies presented in the
last section, it was clear that replicons maintained some of
the same features of poliovirus. Since replicons do not
encode capsid proteins, they do not have the capacity to
reinfect new cells. Thus, injection of replicons in the pe-
riphery should result in localization of expression of GFP,
unless the replicon RNA (or GFP protein) has the capacity
to be transported to the neuronal cell bodies in the CNS. To
address this possibility, we injected naked replicon RNA
into the muscle of PVR mice and determined the expression
of GFP. Poliovirus replicon RNA encoding GFP was in-
jected intramuscularly into the right semitendinosus muscle
and the tissue (Fig. 3) processed identically to that in the
previous section. GFP expression was evident in all animals
(12/12) and the patterns of GFP expression at all locations
designated in Fig. 1b were similar to that seen with encap-
sidated replicons. In Fig. 4a, GFP expression within the
semitendinosus muscle (white arrowheads) is intense within
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the periphery of the muscle and the characteristic banding of
the muscle myofibrils is apparent. Branches of the sciatic
nerve (white arrow) also demonstrated abundant GFP ex-
pression. In contrast, muscle taken from animals that had
received an intramuscular injection of artificial cerebral
spinal fluid (CSF) (n  7) demonstrated diffuse autofluo-
rescence (Fig. 4b) probably due to the paraformaldehyde
fixative (the control panel is imaged at the same laser power
as the replicon injected tissue shown in Fig. 4a). In the
spinal cord of mice injected with the replicon RNA encod-
ing GFP, large triangular cells characteristic of motorneu-
rons demonstrate colocalization of GFP expression and the
NeuN antigen (Fig. 4c). In contrast, no GFP expression is
evident in the spinal cord of an animal that had received an
injection of artificial CSF (Fig. 4d).
To further substantiate that the replicon RNA has the
capacity for expression and transport, rats were given intra-
muscular injections of replicon RNA encoding GFP. Rats
do not encode a poliovirus receptor protein to allow polio-
virus infection. In preliminary studies, we confirmed that
intrathecal inoculation of replicon RNA into rats resulted in
expression of GFP in motor neurons, indicating there was
no block for gene expression in the rat neurons (data not
shown). Following intramuscular inoculation, the rat muscle
Fig. 1. Intramuscular injection of poliovirus replicons. (a) Method of injection. Poliovirus replicons encoding GFP were prepared as previously described
(Ansardi, Porter, and Morrow, 1993; Bledsoe, Gillespie, and Morrow, 2000; Bledsoe et al., 2000) and were diluted to a final concentration of 107 infectious
units with a mixture of sterile artificial CSF. Single injections of 40 l of the replicons encoding GFP or 40 l of sterile artificial CSF were made into the
right semitendinosus muscle of an adult PVR transgenic mouse using a 30-gauge needle attached to a micropipette. Care was taken to prevent bleeding or
excess tissue damage. Juvenile mice received only 20 l of replicons or artificial CSF. (b) Sites in which histological samples were obtained along the
neuromuscular pathway. (Site 1) Longitudinal sections through the semitendinosus muscle adjacent to the site of replicon or artificial CSF injection. In
addition to muscle myofibrils, terminal branches of the sciatic nerve were also sampled. (Site 2) Sections through the sciatic nerve as it branches onto the
semitendinosus muscle. The mixed nerve contains both motor fibers en route to the muscle from the motorneurons of the ventral horn of the spinal cord and
sensory fibers carrying pain and proprioception from the muscle to the dorsal horn of the spinal cord. (Site 3) The dorsal root ganglion of the sensory root
of the spinal nerve containing the nerve cell bodies of the bipolar sensory neurons that transfer information from the muscle to the dorsal spinal cord. (Site
4) The ventral horn of the spinal cord, shown here in cross section at the level of the lumbar enlargement serving the lower limbs. The large, triangularly
shaped cells in the lower half of the spinal cord gray matter are the motorneurons, which send axons out to the muscles to initiate movement. Poliovirus
demonstrates a marked tropism for motorneurons, which is shared by the poliovirus replicons.
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and CNS tissue were processed and analyzed for GFP ex-
pression. The patterns of GFP expression within the semi-
tendinosus muscle and sciatic nerve in rats were indistin-
guishable from the results seen in PVR mice after injection
of replicon RNA (data not shown). Within the CNS of all
the animals (3/3), labeled fibers were seen in the dorsal
spinal cord and large, multipolar cells in the ventral horn
were abundantly labeled with GFP (Fig. 5a). The neuronal
identity of these cells was confirmed by NeuN antibody.
Control sections processed without the antibody to GFP
revealed no expression within the spinal cord motor neurons
(Fig. 5b). Intramuscular injection of artificial CSF (n  2)
(Fig. 5c) or encapsidated poliovirus replicons (n  2) (Fig.
5d) resulted in no GFP expression with the neuronal popu-
lation. The results from these studies then, establish that
replicon RNA or, less likely, protein encoded by replicons,
possess the capacity for transport to the CNS.
Sciatic nerve section after intramuscular injection of
poliovirus replicons or replicon RNA
To compare the peripheral and central production of GFP
following inoculation, a series of adult animals were in-
jected with encapsidated replicons (n  12), replicon RNA
encoding for GFP (n  12), or 1 ng of recombinant GFP
protein at (n  4). In each group, animals were sacrificed at
6 or 72 h after surgery. Six hours’ survival is within the time
course of GFP expression following replicon injection by
other routes (Bledsoe et al., 2000b) but is probably too short
an interval to permit retrograde transport from the axon to
the neuronal cell body and anterograde transport of GFP
back to the axon terminals. Foreign protein expression is
maximal at 72 h after replicon administration (Bledsoe et
al., 2000b), this time interval does allow sufficient time for
transport to and from the motor neuron cell body. In half of
the animals of each replicon- or RNA-treated group, the
right sciatic nerve was cut to prevent retrograde transport
back to the cell body via the sciatic nerve.
In all animals, GFP expression was present within the
injected muscle, regardless of the survival time or sciatic
nerve section (data not shown). GFP expression in the
sciatic nerve close to its entrance into the muscle is shown
in Fig. 6 for animals receiving encapsidated replicon (Fig.
6a–d), replicon RNA (Fig. 6e–h), and recombinant GFP
protein (Fig. 6i and j) and sacrificed at 6 h post-surgery. In
Fig. 6a, anti-GFP staining reveals GFP expression within
the sciatic nerve fibers, whereas a control section (Fig. 6b)
processed without the primary antibody and displayed at the
same laser intensity levels reveals only the background
fluorescence (most probably due to the paraformaldehyde
fixative). Similar results are seen in animals receiving a
sciatic nerve section (Fig. 6c and d), suggesting that GFP
expression has resulted from local translation of replicon
RNA. These results are further supported by the results from
injections of naked replicon RNA. In Fig. 6e a similar
distribution of GFP expression is seen within the sciatic
nerve of a mouse injected with replicon RNA and sacrificed
at 6 h, whereas Fig. 6g is taken from a similar animal with
a sciatic nerve section. Longer survival times revealed that
GFP expression became increasingly robust in the uncut
nerve (see Fig. 2d). In comparison to the 6-h survival, more
GFP is present in the sciatic nerve of animals after 72 h,
presumably due to retrograde transport of the replicon to the
motor neuron cell body, production of large amounts of
foreign protein and anterograde transport of the GFP back to
the sciatic nerve axons. The levels of GFP expression in the
cut sciatic nerve at 72 h were, in contrast, similar to those
shown at 6 h survival and may reflect only local replicon
RNA translation (data not shown). Finally, at the level of
the spinal cord, GFP expression was occasionally apparent
in animals with uncut sciatic nerves sacrificed at 6 h but was
never seen in sections taken from mice that had received
Fig. 2. GFP expression in neuromuscular pathways following intramuscular injection of encapsidated replicons encoding GFP. (a) Confocal scanning
microscope image of a longitudinal frozen section through the right semitendinous muscle (location 1 in Fig. 1b) in a PVR transgenic mouse that had received
an intramuscular injection of replicons encoding GFP 72 h earlier. Anti-GFP staining using a biotinylated secondary, an Alexa 488 (green) fluorochrome,
and an argon laser reveal GFP expression within the cytoplasm of the muscle cells, most noticeable at the periphery of the cells (white arrowheads). Branches
of the sciatic nerve within the muscle (white arrow) exhibit intense GFP expression. Scale bar  40 . (b) Confocal image of a longitudinal frozen section
through the right semitendinous muscle (location 1 in Fig. 1b) in a PVR transgenic mouse that had received an intramuscular injection of artificial CSF 72 h
earlier. Anti-GFP staining using a biotinylated secondary, an Alexa 488 fluorochrome, and an argon laser revealed no GFP expression within the muscle cells
(white arrowheads). The background fluorescence of the myofibrils is due to the paraformaldehyde used to fixate the tissue. Scale bar  40 . (c) Confocal
image of a longitudinal frozen section through the right sciatic nerve (location 2 in Fig. 1b) in a PVR transgenic mouse that had received an intramuscular
injection of replicons encoding GFP in the right semitendinous muscle 72 h earlier. Anti-GFP staining using a biotinylated secondary, an Alexa 488 (green)
fluorochrome, and an argon laser reveals GFP expression in axonal fibers within the nerve. Scale bar  40 . (d) Merged confocal image of the GFP
expression shown in C above and the expression of neuronal antigens using an antibody which identifies neurons, NeuN, a donkey antimouse secondary
conjugated to an Alexa 594 (red) fluorochrome and a krypton laser. GFP expression from the replicons (green) is largely colocalized with NeuN expression
indicative of neuronal identity (red), producing a yellow image in this merged view. Scale bar 40 . (e) Confocal image of a coronal frozen section through
a right dorsal root ganglion (location 3 in Fig. 1b) in a PVR transgenic mouse that had received an intramuscular injection of replicons encoding GFP into
the right semitendinous muscle 72 h earlier. Anti-GFP staining using a biotinylated secondary, an Alexa 488 (green) fluorochrome, and an argon laser reveals
GFP expression in the sensory neuron cell bodies within the ganglion. Scale bar  40 m. (f) Merged confocal image of the GFP expression shown in E
above and the expression of neuronal antigens using the NeuN antibody. A donkey antimouse secondary conjugated to an Alexa 594 (red) fluorochrome and
a krypton laser reveals that GFP expression (green) is largely colocalized with NeuN expression (red), producing a yellow image in this merged view. NeuN
staining is present within many of the neuronal nuclei; other nuclei are not evident in this plane of section. Scale bar  40 .
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Fig. 3. GFP expression in the ventral horn following intramuscular injection of encapsidated replicons encoding GFP. (a) Longitudinal frozen section through
the ventral horn of the right lumbar enlargement of the spinal cord in a PVR transgenic mouse that had received an intramuscular injection of replicons
encoding GFP into the right semitendinous muscle 72 h earlier. Anti-GFP staining using a biotinylated secondary, an Alexa 488 (green) flurochrome, and
an argon laser reveal GFP expression within the cytoplasm of large triangular shaped cells with the characteristic profile of motorneurons (white arrowheads)
as well as other smaller neurons. GFP expression is absent in the nucleus but extends throughout the dendrites and proximal axons so that much of the apparent
background staining is due to cut neuronal processes within the neurophil. Scale bar 40 . (b) The same section in A, showing the ventral horn of the spinal
cord in PVR mouse that had received an intramuscular injection of replicons encoding GFP 72 h earlier. The neuronal population is identified the NeuN
antibody, a donkey antimouse secondary conjugated to an Alexa 594 (red) fluorochrome and visualized with a krypton laser. NeuN expression is found
throughout the nucleus and cytoplasm of the large motorneurons (white arrowheads) as well as other smaller cells. Scale bar  40 . (c) The same section
in A, showing the ventral horn of the spinal cord of a PVR mouse that had received an intramuscular injection of replicons encoding GFP. In this merged
image of the red and green channels, NeuN expression is colocalized with the GFP expression (white arrowheads), indicating that the replicon-infected cells
have a neuronal identity. Scale bar  40 . (d) Longitudinal frozen section through the ventral horn of the right lumbar enlargement of the spinal cord in
a PVR transgenic mouse that had received an intramuscular injection of replicons encoding GFP into the right semitendinous muscle 72 h earlier. This section
was taken from the same animal as in A above but was processed without the anti-GFP primary antibody. Immunohistochemistry using a biotinylated
secondary, an Alexa 488 fluorochrome, and an argon laser reveals no GFP expression within the neurons of the spinal cord. Scale bar  40 . (e) The same
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nerve section. At 72 h, intense GFP expression was seen in
mice with intact sciatic nerves, but was not apparent in the
spinal cords of mice that had received nerve section.
To determine whether GFP expression within the sciatic
nerve and spinal cord was the result from transport across
the neuromuscular junction of the GFP protein produced by
the muscle cells, intramuscular injections of recombinant
GFP protein were administered at 1 ng per injection and the
animals sacrificed at 6 or 72 h after injection (n  12).
Examination of GFP fluorescence and immunofluorescent
analyses utilizing an anti-GFP antibody revealed only a
local distribution of GFP within the muscle fibers surround-
ing the site of injection (data not shown). Longitudinal
sections through the sciatic nerve (Fig. 6i) reveal an absence
of GFP localization identical to that seen in control sections
processed without primary antibody (Fig. 6j). Transport of
GFP protein from the muscle across to the sciatic nerve does
not occur, even at the longer survival time of 72 h (data not
shown).
Enhanced gene expression from replicons in
juvenile animals
A previous study demonstrated that PVR is mainly ex-
pressed early in development, with little or no receptor
expression in adults (Gromeier et al., 2000). To assess the
effect of age on susceptibility to replicon infection, intra-
muscular injections of replicons encoding GFP were made
into juvenile mice (20 days old) and the animals were
sacrificed at survival times ranging from 24 h to 3 months.
GFP expression was found in all (12/12) of the younger
animals sacrificed at 24 h to 5 weeks after injection. The
GFP expression was very intense within the muscle, sciatic
nerve, and dorsal root ganglia, whereas within the spinal
cords, motorneurons were densely labeled as early as 24 h
after intramuscular injection (Fig. 7a). This intense GFP
expression was still apparent at 5 days (Fig. 7b) and 2 weeks
(Fig. 7c) after injection in the younger animals. One month
after injection of replicons an occasional motorneuron ex-
pressing GFP was still apparent (Fig. 7d); GFP expression
above background was absent in all animals (8/8) with
longer survival times of 8 and 12 weeks (data not shown).
For comparison, the time course of GFP expression in
the CNS following intramuscular injection of encapsidated
poliovirus replicons into adult animals was also examined in
adult animals sacrificed at 24 h, 5 days, 2 weeks, and 1
month after injection. The GFP expression is evident as
early as 24 h after injection in all animals (Fig. 7e) and is
still present in most animals (6/8) at 5 days (Fig. 7f), counter
to previous studies using an intrathecal injection technique.
In contrast to the expression seen in juvenile animals, no
localized GFP expression is noted in tissue taken from adult
animals at survival times from 2 weeks to 3 months (0/8)
(Fig. 7g and h).
To assess the possibility that the longer GFP expression
in young animals was due to replicon infection of other cell
types within the CNS, double staining using an anti-GFP
antibody and antibodies against astrocytes, neurons, and
oligodendrocytes was used. GFP expression is prominent
within the large motor neurons of the lumbar spinal cord
(white arrow), but is absent from the cell body or fibers of
astrocytes stained with anti-gfap antibody (Fig. 8a, white
arrowhead). Anti-GFP staining combined with an antibody
against CNPase, a marker for oligodendrocytes and
Schwann cells, reveals that GFP expression is not found
within these cell types visualized in red (white arrowheads),
but only in the motor neurons (Fig. 8b, white arrow). Co-
localization of GFP expression and NeuN expression is
once again found only within ventral horn neurons (Fig. 8c,
white arrow).
Discussion
In this study, we have used replicons encoding GFP to
investigate features of poliovirus gene expression from the
periphery to the CNS following intramuscular inoculation.
We readily detected expression of GFP in muscle tissue.
Expression was also evident in the sciatic nerve, dorsal root
ganglion, and in motorneurons of the ventral horn following
intramuscular inoculation of replicons in PVR mice. Ex-
pression of GFP in CNS neurons was observed following
intramuscular inoculation of replicon RNA in both trans-
genic mice and rats, indicating that replicon RNA probably
possesses the capacity for transport from the periphery to
CNS. Sciatic nerve section prevented retrograde transport of
section as in D (no anti-GFP primary antibody control), stained with an antibody against neurons, NeuN, a donkey antimouse secondary conjugated to an
Alexa 594 (red) fluorochrome and visualized with a krypton laser. NeuN expression is found throughout the nucleus and cytoplasm of the large motorneurons
as well as other smaller cells. Scale bar  40 . (f ) The same section as in C and D (no anti-GFP primary antibody control). NeuN expression is found
throughout the nucleus and cytoplasm of the neurons but no GFP expression is found, confirming the specificity of the antibody used to localize GFP. Scale
bar  40 . (g) Longitudinal frozen section through the ventral horn of the right lumbar enlargement of the spinal cord in a normal PVR transgenic mouse
that received no intramuscular injection. Immunohistochemistry using an anti-GFP primary, a biotinylated secondary, an Alexa 488 (green) fluorochrome,
and an argon laser revealed no GFP expression within the neurons of the spinal cord. The low background fluorescence is due to paraformaldehyde fixation.
Scale bar 40 . (h) The same section in G (normal PVR transgenic mouse), stained with an antibody against neurons, NeuN, a donkey antimouse secondary
conjugated to an Alexa 594 (red) fluorochrome and visualized with a krypton laser. NeuN expression is found throughout the nucleus and cytoplasm of the
large motorneurons as well as other smaller cells. Scale bar 40 . (i) The same section in G and H (normal PVR transgenic mouse). NeuN expression (red)
is found throughout the nucleus and cytoplasm of neurons but no GFP expression is seen, confirming that there is no background level of GFP in these cells.
Scale bar  40 .
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Fig. 4. GFP expression in the semitendinosus muscle and in the lumbar spinal cord following intramuscular injection of poliovirus RNA encoding GFP. (a)
Confocal scanning microscope image of a longitudinal frozen section through the right semitendinosus muscle (location 1 in Fig. 1b) in a PVR transgenic
mouse that had received an intramuscular injection of poliovirus RNA encoding GFP 72 h earlier. Anti-GFP staining using a biotinylated secondary, an Alexa
488 (green) fluorochrome, and an argon laser revealed GFP expression within the cytoplasm of the muscle cells, most noticeable at the periphery of the cells.
Scale bar  40 . (b) Confocal image of a longitudinal frozen section through the right semitendinosus muscle (location 1 in Fig. 1b) in a PVR transgenic
mouse that had received an intramuscular injection of artificial CSF 72 h earlier. Anti-GFP staining using a biotinylated secondary, an Alexa 488
fluorochrome, and an argon laser revealed no GFP expression within the muscle cells. The background fluorescence of the myofibrils is due to the
paraformaldehyde used to fixate the tissue. The apparent fluorescence along the muscle cells is due to an edge effect where the muscle tissue has folded. Scale
bar  40 . (c) Confocal scanning microscope image of a longitudinal frozen section through the ventral horn of the right lumbar enlargement of the spinal
cord (location 4 in Fig. 1b) in a PVR transgenic mouse that had received an intramuscular injection of RNA encoding GFP into the right semitendinosus
muscle 72 h earlier. Anti-GFP staining using a biotinylated secondary, an Alexa 488 (green) fluorochrome, and an argon laser revealed GFP expression within
the cytoplasm of large triangular-shaped cells with the characteristic profile of motorneurons. The neuronal population is identified with an antibody against
neuronal nuclei, NeuN, a donkey antimouse secondary conjugated to an Alexa 594 (red) fluorochrome and visualized with a krypton laser. NeuN expression
is found throughout the nucleus and cytoplasm of the large motorneurons. In this merged image of the red and green channels, NeuN expression is colocalized
with the GFP expression indicating that the RNA-replicon-infected cells have a neuronal identity. Scale bar 40 . (d) Confocal scanning microscope image
of a longitudinal frozen section through the ventral horn of the right lumbar enlargement of the spinal cord (location 4 in Fig. 1b) in a PVR transgenic mouse
that had received an intramuscular injection of artificial CSF into the right semitendinosus muscle 72 h earlier. Anti-GFP staining (green) revealed no GFP
expression within the neurons, although NeuN expression (red) was found throughout the nucleus and cytoplasm. Scale bar  40 .
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poliovirus replicons and replicon RNA, eliminating expres-
sion within the spinal cord motor neuron cell bodies. Some
expression was found within the axonal fibers of the sciatic
nerve, suggesting local synthesis of GFP from replicon
RNA. In contrast, intramuscular injection of recombinant
GFP protein led to no transfer of GFP into the sciatic nerve
Fig. 5. Expression of GFP in the rat lumbar spinal cord following intramuscular injection of poliovirus RNA or encapsidated replicons. (a) Confocal scanning
microscope image of a longitudinal frozen section through the ventral horn of the right lumbar enlargement of the spinal cord (location 4 in Fig. 1b) in a
Sprague–Dawley rat that had received an intramuscular injection of replicon RNA encoding GFP into the right semitendinosus muscle 72 h earlier. Anti-GFP
staining using a biotinylated secondary, an Alexa 488 (green) fluorochrome and an argon laser revealed GFP expression within the cytoplasm of large
triangular shaped cells with the characteristic profile of motorneurons. The neuronal population is identified with an antibody against neurons, NeuN, a donkey
antimouse secondary conjugated to an Alexa 594 (red) fluorochrome and visualized with a krypton laser. NeuN expression is found throughout the nucleus
and cytoplasm of the large motorneurons. In this merged image of the red and green channels, NeuN expression is colocalized with the GFP expression and
appears yellow, indicating that the replicon-infected cells have a neuronal identity. Scale bar  40 . (b) Confocal scanning microscope image of a frozen
longitudinal section of the spinal cord taken from the same animal as in A processed without the anti-GFP primary antibody. The NeuN antibody again
identifies the neuronal population and an Alexa 594 secondary (red,) but no GFP expression is seen, indicating that there is no endogenous reaction to the
GFP antibody. Scale bar  40 . (c) Confocal scanning microscope image of a longitudinal frozen section through Sprague–Dawley rat that had received
an intramuscular injection of artificial CSF into the right semitendinosus muscle 72 h earlier. Anti-GFP staining (green) revealed no GFP expression within
the neurons, although NeuN expression (red) is found throughout the nucleus and cytoplasm. Scale bar  40 . (d) Confocal scanning microscope image
of a longitudinal frozen section through Sprague–Dawley rat that had received an intramuscular injection of encapsidated GFP replicons into the right
semitendinosus muscle 72 h earlier. Anti-GFP staining (green) revealed no GFP expression within the rat motor neurons, which lack the PVR receptor,
although NeuN expression (red) is found throughout the nucleus and cytoplasm. Scale bar  40 .
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the right semitendinosus muscle 6 h earlier. Anti-GFP staining using a biotin-
ylated secondary, an Alexa 488 (green) fluorochrome, and an argon laser
reveals GFP expression in fibers within the nerve. Nuclei and counter-
stained with DAPI and are visualized with an ultraviolet laser. Scale bar 
40 . (b) Confocal image of an adjacent section to that in A, processed
without the primary antibody against GFP. The control image is displayed
at the same laser intensity levels as the previous section. The faint green
fluorescence is due to the paraformaldehyde fixative used, whereas the blue
channel displaying the DAPI-labeled nuclei is equally bright in both the
experimental and control sections. Scale bar  40 . (c) Confocal image
of a longitudinal frozen section through the right sciatic nerve (location 2
in Fig. 1b) in an adult PVR transgenic mouse that had received an intra-
muscular injection of encapsidated replicons encoding GFP in the right
semitendinosus muscle 6 h earlier and a complete section of the sciatic
nerve immediately afterwards. Anti-GFP staining using a biotinylated
secondary, an Alexa 488 (green) fluorochrome and an Argon laser revealed
GFP expression in fibers within the nerve. Nuclei are counterstained with
DAPI and are visualized with an ultraviolet laser. Scale bar  40 . (d)
Confocal image of an adjacent section to that in C, processed without the
primary antibody against GFP. The control image is displayed at the same
laser intensity levels as the previous section. The faint green fluorescence
is probably due to the paraformaldhehyde fixative used, whereas the blue
channel displaying the DAPI-labeled nuclei is equally bright in both the
experimental and control sections. Scale bar  40 . (e) Confocal image
of a longitudinal frozen section through the right sciatic nerve (location 2
in Fig. 1b) in an adult PVR transgenic mouse that had received an intra-
muscular injection of replicon RNA encoding GFP in the right semitendi-
nosus muscle 6 h earlier. Anti-GFP staining using a biotinylated secondary,
an Alexa 488 (green) fluorochrome, and an argon laser revealed GFP
expression in cell bodies and fibers within the nerve. Nuclei are counter-
stained with DAPI and are visualized with an ultraviolet laser. Scale bar 
40 . (f) Confocal image of an adjacent section to that in E, processed
without the primary antibody against GFP. The control image is displayed
at the same laser intensity levels as the previous section. The faint green
fluorescence is probably due to the paraformaldhehyde fixative used,
whereas the blue channel displaying the DAPI-labeled nuclei is equally
bright in both the experimental and control sections. Scale bar  40 . (g)
Confocal image of a longitudinal frozen section through the right sciatic
nerve (location 2 in Fig. 1b) in an adult PVR transgenic mouse that had
received an intramuscular injection of replicon RNA encoding GFP in the
right semitendinosus muscle 6 h earlier and a complete section of the
sciatic nerve immediately afterwards. Anti-GFP staining using a biotinyl-
ated secondary, an Alexa 488 (green) fluorochrome, and an argon laser
reveals GFP expression in cell bodies and fibers within the nerve. Nuclei
are counterstained with DAPI and are visualized with an ultraviolet laser.
Scale bar  40 . (h) Confocal image of an adjacent section to that in
G, processed without the primary antibody against GFP. The control
image is displayed at the same laser intensity levels as the previous
section. The faint green fluorescence is probably due to the
paraformaldhehyde fixative used, whereas the blue channel displaying
the DAPI-labeled nuclei is equally bright in both the experimental and
control sections. Scale bar  40 . (i) Confocal image of a longitudinal
frozen section through the right sciatic nerve (location 2 in Fig. 1b) in
an adult PVR transgenic mouse that had received an intramuscular
injection of 1 ng of recombinant GFP protein in the right semitendino-
sus muscle 6 h earlier. Anti-GFP staining using a biotinylated second-
ary, an Alexa 488 (green) fluorochrome, and an argon laser revealed no
GFP expression in cell bodies and fibers within the nerve. Nuclei are
counterstained with DAPI and are visualized with an ultraviolet laser.
Scale bar  40 . (j) Confocal image of an adjacent section to that in
I, processed without the primary antibody against GFP. The control
image is displayed at the same laser intensity levels as the previous
section. The very faint green fluorescence is due to the paraformaldhe-
hyde fixative used, whereas the blue channel displaying the DAPI-
labeled nuclei is equally bright in both the experimental and control
sections. Scale bar  40 .
Fig. 6. GFP expression in the cut and uncut sciatic nerve following intramus-
cular injection of encapsidated replicons or replicon RNA encoding for GFP.
(a) Confocal image of a longitudinal frozen section through the right sciatic
nerve (location 2 in Fig. 1b) in an adult PVR transgenic mouse that had
received an intramuscular injection of encapsidated replicons encoding GFP in
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or spinal cord. The intramuscular inoculation of juvenile
animals with replicons encoding GFP also resulted in ex-
pression of GFP in motorneurons of the CNS that remained
detectable for a longer time compared to that found in adult
animals.
Previous studies have established that intramuscular in-
oculation of transgenic mice with wild-type poliovirus re-
sults in the development of symptoms consistent with that
seen for poliomyelitis (Arita et al., 1999; Ohka et al., 1998;
Ren and Racaniello, 1992b). The results from these studies
also established that poliovirus replicated in the muscle of
the transgenic mice albeit at a relatively low efficiency. The
intense expression of GFP in the sciatic nerve is consistent
with previous studies that found that poliovirus replicates to
relatively high titers at these sites following intramuscular
inoculation (Ohka et al., 1998; Ren and Racaniello, 1992b).
Similar to what has been shown in wild-type virus, we also
found the intramuscular inoculation of replicons encoding
GFP resulted in expression of GFP in the motorneurons of
the anterior horn of the spinal cord. The results from pre-
vious studies had suggested that the expression of poliovirus
related proteins in the motorneurons of the anterior horn of
the spinal cord was due to retrograde transport of the intact
poliovirions to the spinal cord, which were subsequently
uncoated in the cytoplasm of the motor neurons to allow
expression of the poliovirus proteins (Ohka et al., 1998).
Since replicons are encapsidated into authentic poliovirus,
they could also be transported via the retrograde fast trans-
port system in the CNS to allow expression of GFP in the
cytoplasm of CNS neurons. However, the results of our
second series of experiments demonstrate the expression of
GFP in motorneurons of the anterior horn following naked
replicon RNA inoculation, suggesting that additional trans-
port mechanisms could be involved for the expression of the
poliovirus in the CNS following intramuscular inoculation.
One intriguing possibility is that following intramuscular
inoculation of replicon RNA, local RNA amplification and
expression of GFP occurs within the axon. The replicon
RNA (and possibly the GFP protein) is then transported to
the dorsal root ganglion and motorneuron cell bodies in the
CNS. The transport of the replicon RNA is consistent with
previous studies describing translocation of RNA in neurons
(Alvarez et al., 1999; Carson et al., 1998; Kiebler and
DesGroseillers, 2000; Knowles et al., 1996, 2000; Oleyni-
kov and Singer, 1998; Schuman, 1999; Steward, 1997).
What remains unclear is the source of the GFP in the
peripheral sciatic nerve axons. One possibility, supported by
our results with the sciatic nerve section, is localized ex-
pression of GFP from the replicon. The localized translation
of mRNA in neurons has been known for some time (Al-
varez et al., 1999; Carson et al., 1998; Kiebler and DesGro-
seillers, 2000; Knowles et al., 1996; Koenig et al., 2000;
Oleynikov and Singer, 1998; Schuman, 1999 Steward,
1997). In fact, RNA containing granules with polyA mRNA
have been shown to localize with 60S ribosome subunits
and eEF-1 in a translational unit localized to dendrites
(Knowles et al., 1996). Translation in axons has now been
well documented in invertebrates and in regenerating axons;
recent studies in mammals have shown that ribosomes do
exist in the adult axon in discrete domains just beneath the
axonal cell membrane, providing a substrate for local pro-
tein synthesis (Alvarez et al., 1999; Koenig et al., 2000).
The unique features of the poliovirus internal ribosome
entry site (IRES) could also facilitate translation in the
microenvironment of the axon (Wimmer et al., 1993). Al-
ternatively, it is possible the replicon RNA is transported to
the neuron cell body and undergoes translation/replication;
the expressed GFP protein is then transported back to the
periphery. At present, features of protein and RNA transport
in neurons are still controversial, making it difficult to
discern between the mechanism of GFP expression in the
periphery and CNS (Alvarez et al., 1999; Burack et al.,
Fig. 7. Comparison of GFP expression in the CNS of juvenile and adult mice following intramuscular injection. (a) Confocal scanning microscope image
of a longitudinal frozen section through the lumbar spinal cord in a 21-day-old PVR mouse. This animal had received an intramuscular injection of replicons
encoding GFP 24 h earlier. Abundant labeling of large motor neurons with GFP expression is visualized by using an anti-GFP antibody, a biotinylated
secondary, and an Alexa 488 fluorochrome. Scale bar  40 . (b) Confocal scanning microscope image of a longitudinal frozen section through the lumbar
spinal cord in a 27-day-old PVR mouse. This animal had received an intramuscular injection of replicons encoding for GFP 5 days earlier. Abundant labeling
of large motor neurons with GFP expression is visualized by using an anti-GFP antibody, a biotinylated secondary, and an Alexa 488 fluorochrome. Scale
bar 40 . (c) Confocal scanning microscope image of a longitudinal frozen section through the lumbar spinal cord in a 34-day-old PVR mouse. This animal
had received an intramuscular injection of replicons encoding for GFP 2 weeks earlier. Large motor neurons with GFP expression are visualized by using
an anti-GFP antibody, a biotinylated secondary, and an Alexa 488 fluorochrome. Scale bar 40 . (d) Confocal scanning microscope image of a longitudinal
frozen section through the lumbar spinal cord in a 58-day-old PVR mouse. This animal had received an intramuscular injection of replicons encoding for
GFP 1 month earlier. Occasional labeling of large motor neurons with GFP expression is visualized by using an anti-GFP antibody, a biotinylated secondary,
and an Alexa 488 fluorochrome. Scale bar 40 m. (e) Confocal scanning microscope image of a longitudinal frozen section through the lumbar spinal cord
in an adult PVR mouse. This animal had received an intramuscular injection of replicons encoding for GFP 24 h earlier. Labeling of large motor neurons
with GFP expression is visualized by using an anti-GFP antibody, a biotinylated secondary, and an Alexa 488 fluorochrome. Scale bar 40 m. (f ) Confocal
scanning microscope image of a longitudinal frozen section through the lumbar spinal cord in an adult PVR mouse. This animal had received an intramuscular
injection of replicons encoding for GFP 5 days earlier. Labeling of large motor neurons with GFP expression is visualized by using an anti-GFP antibody,
a biotinylated secondary, and an Alexa 488 fluorochrome. Scale bar 40 . (g) Confocal scanning microscope image of a longitudinal frozen section through
the lumbar spinal cord in an adult PVR mouse. This animal had received an intramuscular injection of replicons encoding for GFP 2 weeks earlier. GFP
expression, visualized by using an anti-GFP antibody, a biotinylated secondary, and an Alexa 488 fluorochrome, is not evident. Scale bar 40 . (h) Confocal
scanning microscope image of a longitudinal frozen section through the lumbar spinal cord in an adult PVR mouse. This animal had received an intramuscular
injection of replicons encoding for GFP 1 month earlier. GFP expression, visualized by using an anti-GFP antibody, a biotinylated secondary, and an Alexa
488 fluorochrome, is not evident. Scale bar  40 .
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2000; Koenig et al., 2000). Recent studies on neuronal
circuits indicate that GFP and other proteins were not trans-
ported retrogradely unless coupled as a fusion protein with
a nontoxic fragment of tetanus toxin (Bordet et al., 2001;
Coen et al., 1997; Figueiredo et al., 1997; Maskos et al.,
2002). Recombinant GFP injected into the thigh muscles of
PVR mice remains localized within the muscle and does not
cross the neuromuscular junction; thus, no fluorescence is
found within the sciatic nerve or spinal cord. The fact that
we observed the expression in motorneurons after intramus-
cular inoculation of replicon RNA in rats established that
expression of the poliovirus receptor in cells is not a pre-
requisite for transport to the CNS. Thus, in the case of
poliovirus, the translocation of polio (and replicon) RNA to
the CNS could contribute to the production of virus in the
CNS. Further support for this idea comes from the analysis
of GFP expression in animals in which the sciatic nerve was
sectioned. Previous studies have shown that intramuscular
inoculation of poliovirus requires an intact sciatic nerve for
the transport of virus to the CNS (Ren and Racaniello,
1992b). Using a similar approach, we found that intramus-
cular inoculation of replicons followed by sectioning the
sciatic nerve resulted in GFP expression in the peripheral
nerves. This result is consistent with the localized expres-
sion of GFP and, although not described for poliovirus,
localized protein expression in neurons has been previously
described (Alvarez et al., 1999; Kiebler and DesGroseillers,
2000). Additional studies with the replicon encoding GFP
will be needed to ascertain the feature of localized protein
synthesis and how poliovirus has adapted to capitalize on
this feature for gene expression.
Fig. 8. Cell specificity of GFP expression in the CNS of juvenile animals
following intramuscular inoculation or replicons. (a) Confocal scanning
microscope image of a longitudinal frozen section through the lumbar
spinal cord in a 23-day-old PVR mouse. This animal had received an
intramuscular injection of replicons encoding for GFP 72 h earlier. The
white arrow indicates a large motor neuron with GFP expression, visual-
ized by using an anti-GFP antibody and a biotinylated secondary and an
Alexa 488 (green) fluorochrome. Astrocytic fibers and cell bodies are
stained with an antibody against gfap and an Alexa (red) 594 secondary
antibody. The white arrowhead indicates the location of an astrocytic cell
body; GFP expression is missing in this area. Scale bar  40 . (b)
Confocal scanning microscope image of a longitudinal frozen section
through the lumbar spinal cord in a 23-day-old PVR mouse. This animal
had received an intramuscular injection of replicons encoding for GFP 72 h
earlier. The white arrow indicates a large motor neuron with GFP expres-
sion, visualized by using an anti-GFP antibody, a biotinylated secondary,
and an Alexa 488 (green) fluorochrome. A monoclonal antibody against
CNPase, a marker for oligodendrocytes and Schwann cells, is visualized
using an Alexa 594 (red) secondary antibody. The white arrowheads
indicate oligodendrocyte cell bodies. No GFP expression is found within
these cell types. Scale bar  40 . (c) Confocal scanning microscope
image of a longitudinal frozen section through the lumbar spinal cord in a
23-day-old PVR mouse. This animal had received an intramuscular injec-
tion of replicons encoding for GFP 72 h earlier. The white arrow indicates
a large motor neuron with GFP expression, visualized by using an anti-GFP
antibody, a biotinylated secondary, and an Alexa 488 (green) fluoro-
chrome. The neuronal identity of the GFP-labeled cells is confirmed by
anti-NeuN and an Alexa 594 (red) secondary antibody. Scale bar  40 .
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In our previous studies, we have demonstrated that rep-
licons encoding foreign genes (including GFP) could be
used for gene delivery to the CNS (Bledsoe et al., 2000a;
Bledsoe et al., 2000b; Jackson et al., 2001). For these
studies, we relied on the use of surgical procedures to
directly inoculate the replicons into the spinal cord or CSF
of the transgenic animals. The results of our current study,
along with our previous reports, support the idea that po-
liovirus replicons could be used for gene delivery to the
CNS via intramuscular inoculation. To substantiate this
claim, we have analyzed the gene expression in the CNS
following intramuscular inoculation of replicons in both
young and adult animals. The results of our studies establish
that in both an adult and young animals, replicons can be
used to express foreign genes in motorneurons of the CNS
for periods of up to 5 days in adults and even longer times
(2 weeks to 1 month) in younger animals. GFP expression
was not evident within the brain after intramuscular injec-
tion of replicons into young or adult animals, suggesting
that transynaptic transport of replicons does not occur. The
time course of expression of foreign genes for replicons
following intramuscular inoculation of adults is consistent
with our previous studies utilizing an intrathecal route of
replicon delivery into the CSF. What was surprising was the
extended expression of foreign protein by replicons follow-
ing intramuscular inoculation of young animals. There are
several explanations for the longer expression in young
animals. The first could be greater numbers of poliovirus
receptor molecules on the peripheral nerves, leading to a
more vigorous initial infection of the younger animals.
Indeed, previous studies have shown that the poliovirus
receptor gene expression is most active prior to birth and
progressively becomes less as the animal ages (Gromeier et
al., 2000). A second possibility is that the intracellular
milieu of young neurons is more favorable for poliovirus
infection. With respect to this issue it is important to note
that since replicons undergo only a single round of infection
and cannot spread from cell to cell, that the intramuscular
inoculation of young animals did not result in any observ-
able pathogenesis (i.e., paralysis). Even with the enhanced
expression of foreign genes from replicons given to younger
animals, the tropism of poliovirus was maintained for mo-
torneurons of the anterior horn and lower brainstem. We
detected no expression of GFP in other resident cells of the
CNS. The gene expression following intramuscular inocu-
lation was localized within the spinal cord. In contrast, we
found expression of GFP in neurons throughout the CNS
following intrathecal inoculation of replicons, presumably
due to the capacity of the replicons to be transported in the
CSF to locations away from the site of inoculation where
they would infect resident neurons (Jackson et al., 2001).
Collectively, the results of these studies establish that
replicons given via intramuscular route can be effective for
gene delivery to the CNS. One concern might be that the
human population has preexisting immunity to poliovirus as
a result of the immunizations given to children. However,
previous studies have demonstrated that even immunized
animals with circulating antibodies to poliovirus are still
susceptible to poliovirus or replicons following intramuscu-
lar inoculation (Porter et al., 1997). In our previous studies,
we demonstrated that animals previously immunized with
poliovirus could still be immunized with replicons encoding
the C fragment of tetanus toxin, which is a particularly
immunogenic protein that allows the production of an im-
mune response to the C fragment of tetanus toxin (Porter et
al., 1997); we also found that intramuscular injection of
replicons encoding GFP into animals previously immunized
against poliovirus resulted in GFP expression the CNS
(Jackson and Morrow, unpublished). We anticipate then that
there would be no serious determent to the administration of
replicons encoding foreign proteins of potential benefit to
the CNS when given via the intramuscular route. Additional
studies will use replicons encoding small biologically active
proteins to determine whether this route will be useful for
delivery of these proteins to the CNS and to determine the
effects of multiple intramuscular injections of these repli-
cons.
Materials and methods
Preparation of encapsidated poliovirus replicons
encoding GFP
In a previous study, we have described the methods for
the construction of poliovirus replicon encoding GFP (Jack-
son et al., 2001). The gene encoding GFP was positioned
between the VP0 and 2A protease genes of the poliovirus
genome. To facilitate expression of GFP, an additional
DNA sequence was inserted encoding the self-cleaving pep-
tide from foot-and-mouth disease virus (FMDV). After
translation, the self-cleaving autocatalytic activity of the
FMDV peptide cleaves between VP0 and the amino termi-
nus of GFP; the carboxyl terminus of GFP is generated by
self-cleavage of the 2A protease from the poliovirus ge-
nome. The replicon encoding GFP was used to characterize
the infection and gene expression following intrathecal de-
livery of replicons into the spinal columns of transgenic
animals. The replicon was encapsidated into poliovirus us-
ing a complementation system previously described by our
laboratory (Ansardi et al., 1993, 1996). Prior to use in the
current study, the purified replicons were tested for polio-
virus and vaccinia virus (used to supply the capsids) using
an infectious assay previously described (Bledsoe et al.,
2000a). In our previous experiments, we have demonstrated
that infection of the CNS with this replicon results in the
production of GFP in motorneurons that can be visualized
by immunohistochemistry using anti-GFP antibodies; this
method proved to be more sensitive than autofluorescence
of GFP (Jackson et al., 2001). In this case, we found that the
expression of GFP was localized to the cytoplasm of the
infected neurons and was dependent on replication of the
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replicon RNA (Bledsoe et al., 2000a; Choi, Pal-Ghosh, and
Morrow, 1991; Jackson et al., 2001). The exclusivity of
neuron infection was confirmed using double labeling with
antibodies specific for neurons (NeuN) (Mullen et al., 1992;
Wolf et al., 1996); we found no staining in astrocytes or
microglial cells present in the CNS (Bledsoe et al., 2000b;
Jackson et al., 2001).
For injection of replicon RNA, in vitro transcription was
used on the replicon that was previously linearized with the
restriction enzyme SalI. The procedures used for in vitro
transcription have been previously published (Choi et al.,
1991). Following transcription, the RNA was purified using
a Qiagen RNA purification kit. The RNA was eluted in
RNase free H20 and made isotonic with 5% glucose and
phosphate-buffered saline (PBS) at a concentration of 1
mg/ml with 10 units of RNAsin (Promega, Madison WI).
GFP was expressed in Escherichia coli and purified using a
six-histidine affinity tag (Novak et al., 2003). The recom-
binant GFP was detoxified to remove bacterial toxins prior
to injection.
Intramuscular injections of transgenic animals
Adult mice transgenic for the poliovirus receptor re-
ceived a single injection of 107 poliovirus replicons encod-
ing GFP in 40 l (n  30); artificial cerebrospinal fluid
(CSF) (without glucose) (126 mM NaCl, 3.5 mM KCl, 1.2
mM Na2P04, 1.3 mM MgCl2, 2.0 mM CaCl2, 25 mM
NaHCO3) was used as a control (n  7). An additional
group of adult mice (n  12) received single intramuscular
injections of 40 l of poliovirus RNA encoding GFP in-
jected into the right semitendinosus muscle. Juvenile ani-
mals (20 days old) were injected in the same manner using
GFP replicons (n 20), artificial CSF (n 4), or poliovirus
replicon RNA encoding GFP (n  11). Adult Sprague–
Dawley rats received single intramuscular injections of po-
liovirus replicons (n 2), artificial CSF (n 2), or replicon
RNA (n  3).
The replicons were administered slowly via a 30-gauge
needle attached to a micropipette (Fig. 1a) (Jackson et al.,
2001). Little blood or tissue damage was noted at the time
of injection. Possible changes in sensorimotor function were
assessed in the injected animals using a multitest scale for
behavioral function the CMBS (Jackson et al., 2001). After
various survival times ranging from 24 h to 3 months, the
mice were given a mixture of ketamine and Rompun and
sacrificed by vascular perfusion with 0.9% saline followed
by 4% paraformaldehyde in 0.1 M PBS. The spinal column,
brain, and muscles of the right thigh were dissected out and
stored in 4% paraformaldehyde overnight. Following infil-
tration with 30% sucrose, frozen cryostat sections were cut
in the longitudinal or coronal plane at 10–12 m, placed on
microscope slides, and stored at 4°C.
An additional series of adult mice received an intramus-
cular injection of poliovirus replicons encoding GFP (n 
12), replicon RNA encoding GFP (n  12), or recombinant
GFP protein (n  4). In addition, six mice in each replicon
or RNA group underwent section of the right sciatic nerve
proximal to the spinal cord before peripheral branches are
distributed. Care was taken to prevent damage to the adja-
cent femoral artery. The mice were sacrificed at 6 or 72 h
after injection, and the spinal cords, sciatic nerves, and
muscles were processed for GFP immunofluorescence.
Histological and immunofluorescent analyses
Representative slides taken from the locations identified
in Fig. 1b were stained with hematoxylin and eosin to reveal
any adverse inflammatory cell responses in the replicon
injected tissues in comparison to CSF-injected controls
(Bledsoe, et al., 2000a, 2000b; Jackson et al., 2001). For
immunofluorescent analyses, sections throughout each of
the tissues were rinsed three times with 0.1 M PBS, placed
in 10% normal donkey serum for 1 h at room temperature,
and incubated at 4°C overnight with an anti-GFP primary
antibody (Invitrogen, Carlsbad, CA) diluted in 0.3% Triton-
X-100. Sections were rinsed three times in PBS followed by
a 2-h incubation at room temperature with a biotinylated
donkey antirabbit secondary (Jackson Immunoresearch,
West Grove, PA) diluted 1:200 in 0.3% Triton -X-100. An
Alexa 488 (green) streptavidin conjugate (Molecular
Probes, Eugene OR) was then applied for 1 h. The sections
were washed three times in PBS, once in distilled water and
coverslipped in Permafluor (Shandon, Allison Park, PA) or
processed for colocalization (Bledsoe et al., 2000; Jackson
et al., 2001).
Colocalization of neuronal antigens in the spinal cord
and brain tissue was achieved by using a monoclonal pri-
mary antibody against neuronal nuclei, NeuN (Chemicon,
Temecula, CA), and a Alexa 594 (red) donkey antimouse
secondary (Molecular Probes, Eugene, OR). A primary an-
tibody against gfap (Sigma, St. Louis, MO) was used in a
similar manner to localize astrocytes, whereas oligodendro-
cytes and Schwann cells were identified with a monoclonal
antibody against CNPase (Sigma, St. Louis, MO) (Bledsoe
et al., 2000b; Jackson et al., 2001).
Slides from each of the locations outlined in Fig. 1b were
analyzed using a Leitz DIRMBE confocal microscope
equipped with an argon, krypton, and ultraviolet laser. Con-
trol slides from each animal were shot at the same laser
settings to assess background levels of fluorescence due to
fixation and tissue processing. The images were processed
using Adobe Photoshop 6.0.
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